267 related articles for article (PubMed ID: 28981841)
1. CANADIAN POPULATION RISK OF RADON INDUCED LUNG CANCER-VARIATION RANGE ASSESSMENT BASED ON VARIOUS RADON RISK MODELS.
Chen J
Radiat Prot Dosimetry; 2017 Nov; 177(1-2):63-68. PubMed ID: 28981841
[TBL] [Abstract][Full Text] [Related]
2. COMPARATIVE STUDY OF RADON EXPOSURE IN CANADIAN HOMES AND URANIUM MINES-A DISCUSSION ON THE IMPORTANCE OF NATIONAL RADON PROGRAM.
Chen J
Radiat Prot Dosimetry; 2017 Nov; 177(1-2):83-86. PubMed ID: 28981856
[TBL] [Abstract][Full Text] [Related]
3. LIFETIME LUNG CANCER RISKS ASSOCIATED WITH INDOOR RADON EXPOSURE BASED ON VARIOUS RADON RISK MODELS FOR CANADIAN POPULATION.
Chen J
Radiat Prot Dosimetry; 2017 Apr; 173(1-3):252-258. PubMed ID: 27886988
[TBL] [Abstract][Full Text] [Related]
4. Exposure to residential radon causes lung cancer. For the proposition.
Field RW
Med Phys; 2003 Apr; 30(4):485-6. PubMed ID: 12722798
[No Abstract] [Full Text] [Related]
5. Exposure to residential radon causes lung cancer. Against the proposition.
Duport PJ
Med Phys; 2003 Apr; 30(4):486-8. PubMed ID: 12722799
[No Abstract] [Full Text] [Related]
6. RISK ASSESSMENT FOR RADON EXPOSURE IN VARIOUS INDOOR ENVIRONMENTS.
Chen J
Radiat Prot Dosimetry; 2019 Dec; 185(2):143-150. PubMed ID: 30624757
[TBL] [Abstract][Full Text] [Related]
7. Population attributable fraction for lung cancer due to residential radon in Switzerland and Germany.
Menzler S; Piller G; Gruson M; Rosario AS; Wichmann HE; Kreienbrock L
Health Phys; 2008 Aug; 95(2):179-89. PubMed ID: 18617799
[TBL] [Abstract][Full Text] [Related]
8. Population attributable risk associated with lung cancer induced by residential radon in Canada: Sensitivity to relative risk model and radon probability density function choices: In memory of Professor Jan M. Zielinski.
Al-Arydah M
Sci Total Environ; 2017 Oct; 596-597():331-341. PubMed ID: 28437651
[TBL] [Abstract][Full Text] [Related]
9. RADON REFERENCE LEVELS AND PRIORITY AREAS CONSIDERING OPTIMISATION AND AVERTABLE LUNG CANCERS.
Bochicchio F; Venoso G; Antignani S; Carpentieri C
Radiat Prot Dosimetry; 2017 Nov; 177(1-2):87-90. PubMed ID: 28981794
[TBL] [Abstract][Full Text] [Related]
10. Indoor Radon and Lung Cancer: Estimation of Attributable Risk, Disease Burden, and Effects of Mitigation.
Kim SH; Koh SB; Lee CM; Kim C; Kang DR
Yonsei Med J; 2018 Nov; 59(9):1123-1130. PubMed ID: 30328328
[TBL] [Abstract][Full Text] [Related]
11. Calculation of lifetime lung cancer risks associated with radon exposure, based on various models and exposure scenarios.
Hunter N; Muirhead CR; Bochicchio F; Haylock RG
J Radiol Prot; 2015 Sep; 35(3):539-55. PubMed ID: 26083042
[TBL] [Abstract][Full Text] [Related]
12. Utility gains from reductions in the modifiable burden of lung cancer attributable to residential radon in Canada.
Gaskin J; Coyle D; Whyte J; Krewski D
Can J Public Health; 2018 Aug; 109(4):598-609. PubMed ID: 30264193
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric challenges for residential radon epidemiology.
Steck DJ; Field RW
J Toxicol Environ Health A; 2006 Apr; 69(7):655-64. PubMed ID: 16608831
[TBL] [Abstract][Full Text] [Related]
14. Residential radon in Canada: an uncertainty analysis of population and individual lung cancer risk.
Brand KP; Zielinski JM; Krewski D
Risk Anal; 2005 Apr; 25(2):253-69. PubMed ID: 15876202
[TBL] [Abstract][Full Text] [Related]
15. Canadian population risk of radon induced lung cancer: a re-assessment based on the recent cross-Canada radon survey.
Chen J; Moir D; Whyte J
Radiat Prot Dosimetry; 2012 Nov; 152(1-3):9-13. PubMed ID: 22874897
[TBL] [Abstract][Full Text] [Related]
16. A combined analysis of North American case-control studies of residential radon and lung cancer.
Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Field RW; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
J Toxicol Environ Health A; 2006 Apr; 69(7):533-97. PubMed ID: 16608828
[TBL] [Abstract][Full Text] [Related]
17. An overview of the North American residential radon and lung cancer case-control studies.
Field RW; Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
J Toxicol Environ Health A; 2006 Apr; 69(7):599-631. PubMed ID: 16608829
[TBL] [Abstract][Full Text] [Related]
18. Radon blues.
Watts G
BMJ; 2005 Jan; 330(7485):226-7. PubMed ID: 15613367
[No Abstract] [Full Text] [Related]
19. Quantitative Health Risk Assessment of Indoor Radon: A Systematic Review.
Ajrouche R; Ielsch G; Cléro E; Roudier C; Gay D; Guillevic J; Laurier D; Le Tertre A
Radiat Prot Dosimetry; 2017 Nov; 177(1-2):69-77. PubMed ID: 29036475
[TBL] [Abstract][Full Text] [Related]
20. Estimating the burden of lung cancer in Canada attributed to occupational radon exposure using a novel exposure assessment method.
Ge CB; Kim J; Labrèche F; Heer E; Song C; Arrandale VH; Pahwa M; Peters CE; Demers PA
Int Arch Occup Environ Health; 2020 Oct; 93(7):871-876. PubMed ID: 32232555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
